Conclusion of non-exclusive discount agreements pursuant to §130a para. 8 SGB V for various active ingredients/combinations with the possibility of concluding at any time within the scope of the so-called Open House procedure

… via your registration on the "DTVP" allocation platform under the "Communication" tab. Information and answers about other bodies are not binding. A prerequisite for the conclusion of a contract is that the interested pharmaceutical company submits the required procedural documents in full and signed. Any pharmaceutical company that meets the eligibility requirements and documents this by signing the declarations and discount agreement can join the discount agreement. NEW: The option of qualified electronic signature via FP Sign is now also offered. For more information, please refer to the "Procedural Information" form. There is no exclusivity. Accession or conclusion of the contract may take place at any time and under the same conditions. Individual contract negotiations are not carried out. The start of the contract can only be one month at a time. The earliest contract start date is 01.10.2025. On this basis, the maximum duration of the contract is 22 months. The contract ends no later than 31.07.2027, regardless of the date of conclusion of the contract. The tender must be submitted at the beginning of the contract by 01.10.2025 at the latest by 26.08.2025; However, no contracts will be concluded by AOK Nordost before 08.09.2025. For a later start of the contract, the deadline for the submission of tenders is the 5th of the previous month. (Example: Contract start 01.11.2025; Deadline for submission of tenders: 05.10.2025). Should AOK Nordost award an exclusive contract for the active substance(s)/combination of active substances within the framework of an open procedure during the contract period, the contractual provisions concluded within the framework of this publication shall apply. This publication does not constitute the award of a public contract within the meaning of the Public Procurement Coordination Directive 2014/24/EU of the European Parliament and of the Council or of public procurement law. Publication in the Supplement to the Official Journal of the European Union shall be carried out in order to ensure the widest possible degree of transparency with regard to the intended conclusion of contracts. In the absence of a publication form, this form of contract notice shall be used. The resulting conceptual requirements, such as the procedural designation of open proceedings, are solely due to the use of this notice form and the publication platform. A further meaning, in particular a submission to public procurement regulations, insofar as they are not obligated for legal reasons, is not associated with this. An announcement of the awarded contracts takes place exclusively under the following link: https://www.aok.de/gp/medicinal products/discount contract background.